Zobrazeno 1 - 10
of 180
pro vyhledávání: '"Chris J Packard"'
Autor:
Keith Millar, Suzanne M Lloyd, Jennifer S McLean, G David Batty, Harry Burns, Jonathan Cavanagh, Kevin A Deans, Ian Ford, Alex McConnachie, Agnes McGinty, Réne Mõttus, Chris J Packard, Naveed Sattar, Paul G Shiels, Yoga N Velupillai, Carol Tannahill
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58256 (2013)
Associations between socio-economic status (SES), personality and inflammation were examined to determine whether low SES subjects scoring high on neuroticism or hostility might suffer relatively higher levels of inflammation than affluent subjects.I
Externí odkaz:
https://doaj.org/article/a09e69eb0f854c44a6e820707a576186
Autor:
Ashley M Miller, David Purves, Alex McConnachie, Darren L Asquith, G David Batty, Harry Burns, Jonathan Cavanagh, Ian Ford, Jennifer S McLean, Chris J Packard, Paul G Shiels, Helen Turner, Yoga N Velupillai, Kevin A Deans, Paul Welsh, Iain B McInnes, Naveed Sattar
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47830 (2012)
Preliminary data mostly from animal models suggest the sST2/IL-33 pathway may have causal relevance for vascular disease and diabetes and thus point to a potential novel inflammatory link to cardiometabolic disease. However, the characterisation of s
Externí odkaz:
https://doaj.org/article/7a5c789b2d594a97be013f7439da3359
Autor:
Paul G Shiels, Liane M McGlynn, Alan MacIntyre, Paul C D Johnson, G David Batty, Harry Burns, Jonathan Cavanagh, Kevin A Deans, Ian Ford, Alex McConnachie, Agnes McGinty, Jennifer S McLean, Keith Millar, Naveed Sattar, Carol Tannahill, Yoga N Velupillai, Chris J Packard
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e22521 (2011)
It has previously been hypothesized that lower socio-economic status can accelerate biological ageing, and predispose to early onset of disease. This study investigated the association of socio-economic and lifestyle factors, as well as traditional a
Externí odkaz:
https://doaj.org/article/8496f7f55821490cb33b0ae42eee5f8e
Autor:
Naveed Sattar, Heather M Murray, Paul Welsh, Gerard J Blauw, Brendan M Buckley, Stuart Cobbe, Anton J M de Craen, Gordon D Lowe, J Wouter Jukema, Peter W Macfarlane, Michael B Murphy, David J Stott, Rudi G J Westendorp, James Shepherd, Ian Ford, Chris J Packard, Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Study Group
Publikováno v:
PLoS Medicine, Vol 6, Iss 6, p e1000099 (2009)
BACKGROUND: Circulating inflammatory markers may more strongly relate to risk of fatal versus nonfatal cardiovascular disease (CVD) events, but robust prospective evidence is lacking. We tested whether interleukin (IL)-6, C-reactive protein (CRP), an
Externí odkaz:
https://doaj.org/article/0d733b123362413581963ddbd615e44f
Autor:
Ian Ford, Vladimir Bezlyak, David J Stott, Naveed Sattar, Chris J Packard, Ivan Perry, Brendan M Buckley, J Wouter Jukema, Anton J M de Craen, Rudi G J Westendorp, James Shepherd
Publikováno v:
PLoS Medicine, Vol 6, Iss 1, p e16 (2009)
BACKGROUND: Reduced glomerular filtration rate (GFR) is associated with increased cardiovascular risk in young and middle aged individuals. Associations with cardiovascular disease and mortality in older people are less clearly established. We aimed
Externí odkaz:
https://doaj.org/article/ebf73e7b14d8453d8e32236854fff92f
Autor:
Marja-Riitta Taskinen, Elias Björnson, Niina Matikainen, Sanni Söderlund, Joel Rämö, Mari-Mia Ainola, Antti Hakkarainen, Carina Sihlbom, Annika Thorsell, Linda Andersson, Per-Olof Bergh, Marcus Henricsson, Stefano Romeo, Martin Adiels, Samuli Ripatti, Markku Laakso, Chris J. Packard, Jan Borén
Publikováno v:
JCI Insight, Vol 7, Iss 19 (2022)
Background Apolipoprotein C-III (apoC-III) is a regulator of triglyceride (TG) metabolism, and due to its association with risk of cardiovascular disease, is an emergent target for pharmacological intervention. The impact of substantially lowering ap
Externí odkaz:
https://doaj.org/article/04b0164112e64cf5949fe5d13f341920
Autor:
M. John Chapman, Chris J. Packard
Publikováno v:
Journal of the American College of Cardiology. 81:1565-1568
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e056393b404ec63c6fcf95000768cf32
https://doi.org/10.1016/j.jacc.2023.03.384
https://doi.org/10.1016/j.jacc.2023.03.384
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
Cardiovascular disease (CVD) is the leading cause of death globally. It is well-established based on evidence accrued during the last three decades that high plasma concentrations of cholesterol-rich atherogenic lipoproteins are causatively linked to
Externí odkaz:
https://doaj.org/article/668108ae01c949a7a374f4d9eb1580f9
Publikováno v:
Nature Reviews Cardiology. 19:577-592
Accumulating evidence points to the causal role of triglyceride-rich lipoproteins and their cholesterol-enriched remnants in atherogenesis. Genetic studies in particular have not only revealed a relationship between plasma triglyceride levels and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946e32c51ae991ffa90cb71ee3f92cfa
https://doi.org/10.1038/s41569-022-00676-y
https://doi.org/10.1038/s41569-022-00676-y
Autor:
Marja-Riitta Taskinen, Niina Matikainen, Elias Björnson, Sanni Söderlund, Mari Ainola, Antti Hakkarainen, Nina Lundbom, Carina Sihlbom, Annika Thorsell, Linda Andersson, Martin Adiels, Bolette Hartmann, Carolyn F Deacon, Jens J Holst, Chris J Packard, Jan Borén
Objective Incretins are known to influence lipid metabolism in the intestine when administered as pharmacologic agents. The aggregate influence of endogenous incretins on chylomicron production and clearance is less clear, particularly in light of op
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8135f3ece11b4228560be15012b8492
https://eprints.gla.ac.uk/271096/1/271096.pdf
https://eprints.gla.ac.uk/271096/1/271096.pdf
